SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

29 Jul 2025 16:32

RNS Number : 0414T
Caledonia Investments PLC
29 July 2025
 

 

Caledonia Investments plc

 

Directorate change

 

Caledonia Investments plc ("Caledonia" or the "Company") announces that Lynn Fordham, who has served as a non-executive director of the Company since 1 January 2022, has given notice of her resignation with effect from 31 August 2025.

 

Farah Buckley, who has served on the Board since March 2023, has been appointed as an additional member of the Company's Audit and Risk Committee from 1 August 2025 and will succeed Lynn as its chair on 1 September 2025. The Board will now begin the search for an additional non-executive director.

 

David Stewart, Caledonia's Chair, commented:

 

"On behalf of the Board, I would like to thank Lynn for the considerable contribution that she has made to Caledonia and wish her well for the future.

 

"I am delighted that Farah will join the Audit and Risk Committee and will succeed Lynn as its chair."

 

Enquiries

 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

investorrelations@caledonia.com

 

David Stewart

Chairman

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

 

caledonia@teneo.com

29 July 2025

 

Notes:

 

In accordance with section 430 (2B) of the Companies Act 2006, Caledonia confirms that, other than fees payable to Lynn Fordham as a non-executive director up to the effective date of her resignation, no remuneration or payment has been or will be made in connection with her cessation as a director of the Company.

 

Caledonia Investments plc

 

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

 

Our aim is to generate long-term compounding real returns that outperform inflation by 3%-6% over the medium to long term, and the FTSE All-Share index over 10 years.

 

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return. The result is a well-balanced diversified portfolio of investments with a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUWMUPAGAB
Date   Source Headline
11th Jun 20263:30 pmRNSAnnual report 2026 and notice of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20261:39 pmRNSDirector/PDMR Shareholding
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20269:00 amRNSNet Asset Value(s)
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20265:08 pmRNSDirector/PDMR Shareholding
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202611:02 amRNSCompletion of Stonehage Fleming sale
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20269:42 amRNSDirector/PDMR Shareholding
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:34 pmRNSDirector Declaration
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSBoard changes
19th May 20267:00 amRNSFinal Results
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSNotice of Results
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:32 pmRNSHolding(s) in Company
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 202611:00 amRNSNet Asset Value(s)
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20264:39 pmRNSDirector Declaration
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:47 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20263:51 pmRNS-RQuotedData's In The HotSeat Special
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.